In the two months since Pfizer-BioNTech was granted emergency use authorization (EUA) for its COVID-19 vaccine in children 5 to 11 years of age, the Institute for Safe Medication Practices (ISMP) has received multiple reports of mix-ups between the pediatric formulation and that for individuals 12 years of age or older.
Fortunately, pharmacists can use several vaccination handling and administration techniques to help reduce the risk for confusion, according to ISMP and other safety